Sung W Choi, MD
Interventional Cardiology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
- Since medical school
- 30 years
- University of Virginia School of Medicine, 1996
Offices
2 locations · University of California San Francisco · Regents of the University of California
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · UCSF Health Stanyan Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Choi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A88258 · Current
Licensed to practise in California · since 2004 · expires 2027-11-30 · University of Virginia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$123,980
Medicare paid this office $123,980 for 685 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 155 | $14,130 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $13,996 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 182 | $11,329 | $61 |
| Long return visit (40+ min) | 79 | $10,080 | $119 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $8,368 | $440 |
See all 27 services
| Return visit (30+ min) | 155 | $14,130 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $13,996 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 182 | $11,329 | $61 |
| Long return visit (40+ min) | 79 | $10,080 | $119 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $8,368 | $440 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,297 | $154 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 37 | $7,337 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $7,129 | $68 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 223 | $4,135 | $14 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,016 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 60 | $3,588 | $59 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,239 | $294 |
| New patient visit (60+ min) | 19 | $3,016 | $159 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,622 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 235 | $1,845 | $7 |
| New patient visit (45+ min) | 17 | $1,658 | $98 |
| Short return visit (20+ min) | 24 | $1,450 | $56 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $1,403 | $78 |
| External shock to heart to regulate heart beat | 11 | $1,165 | $97 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $833 | $59 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $804 | $73 |
| Ultrasound of heart, follow-up | 15 | $330 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $236 | $16 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 29 | $140 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $136 | $12 |
| Heart muscle strain imaging | 12 | $112 | $9 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $60 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 12 | More than 32% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
685 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 23% · Women 48% · Also on Medicaid 34% · Health risk score 1.88. Above the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 55% · Atrial fibrillation 43% · Diabetes 40% · Heart failure 37% · Chronic kidney disease 36% · Depression 25% · Cancer 19% · COPD 17% · Dementia 15% · Stroke 14%.
The office billed $865,709, Medicare allowed $161,423 and paid $123,980; for 1,879 services of 59 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 685 | 1,879 | 77 | 1.88 | $865,709 | $123,980 |
| 2023 | 771 | 1,682 | 78 | 1.81 | $811,195 | $117,601 |
| 2022 | 713 | 1,497 | 77 | 1.73 | $752,924 | $108,135 |
| 2021 | 585 | 1,549 | 77 | 2.06 | $762,946 | $119,331 |
| 2020 | 478 | 1,298 | 77 | 1.88 | $711,728 | $103,115 |
| 2019 | 534 | 1,496 | 77 | 1.92 | $828,297 | $116,779 |
| 2018 | 534 | 1,539 | 77 | 1.93 | $886,684 | $125,214 |
| 2017 | 414 | 1,237 | 77 | 1.97 | $638,565 | $95,468 |
| 2016 | 460 | 1,453 | 77 | 2.02 | $510,147 | $107,875 |
| 2015 | 656 | 2,288 | 76 | 2.23 | $582,349 | $167,821 |
| 2014 | 666 | 3,490 | 76 | 1.88 | $535,816 | $165,331 |
| 2013 | 969 | 2,800 | 76 | 1.93 | $625,558 | $180,853 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Return visit (30+ min) | 187 | $22,033 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $14,274 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 219 | $13,670 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $7,923 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,102 | $153 |
| Long return visit (40+ min) | 44 | $5,680 | $114 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,235 | $436 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,583 | $191 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $4,243 | $115 |
| Hospital discharge day management, 30 minutes or less | 30 | $2,374 | $74 |
| New patient visit (60+ min) | 17 | $2,357 | $139 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $2,127 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 294 | $2,109 | $6 |
| New patient visit (45+ min) | 19 | $2,036 | $107 |
| External shock to heart to regulate heart beat | 18 | $1,772 | $98 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,245 | $96 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $1,234 | $69 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,118 | $80 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $895 | $75 |
| Ultrasound of heart, follow-up | 14 | $337 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $305 | $16 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 12 | $281 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $212 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $164 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $87 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $75 | $3 |
2022: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $19,316 | $90 |
| Return visit (30+ min) | 167 | $17,356 | $71 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $11,572 | $62 |
| Long return visit (40+ min) | 49 | $7,379 | $125 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $5,001 | $208 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 41 | $3,601 | $86 |
| New patient visit (45+ min) | 32 | $3,584 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,504 | $175 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $2,756 | $54 |
| New patient visit (60+ min) | 13 | $1,939 | $149 |
| Hospital discharge day management, 30 minutes or less | 26 | $1,752 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 212 | $1,684 | $7 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $1,666 | $72 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,575 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,206 | $63 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,045 | $80 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $903 | $75 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $861 | $61 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 18 | $436 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $388 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $170 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $107 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $90 | $6 |
2021: 19 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $36,767 | $92 |
| Return visit (30+ min) | 158 | $20,595 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 165 | $10,786 | $64 |
| Long return visit (40+ min) | 50 | $7,784 | $120 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 62 | $5,724 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,678 | $173 |
| Hospital discharge day management, 30 minutes or less | 58 | $3,905 | $65 |
| New patient visit (60+ min) | 11 | $1,712 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $1,532 | $55 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $1,220 | $76 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,075 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 106 | $843 | $7 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $548 | $42 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $369 | $25 |
| Ultrasound of heart, follow-up | 14 | $366 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $213 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $185 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $104 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $88 | $3 |
2020: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $18,643 | $94 |
| Long return visit (40+ min) | 135 | $15,698 | $81 |
| Return visit (30+ min) | 117 | $11,837 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 101 | $7,063 | $67 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $6,645 | $475 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,360 | $174 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $3,935 | $231 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $3,833 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 38 | $3,466 | $91 |
| Telephone medical discussion with physician, 21-30 minutes | 32 | $2,791 | $66 |
| Hospital discharge day management, 30 minutes or less | 35 | $2,346 | $67 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,529 | $45 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,404 | $100 |
| New patient visit (45+ min) | 13 | $1,397 | $107 |
| External shock to heart to regulate heart beat | 12 | $1,322 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,249 | $66 |
| New patient visit (60+ min) | 13 | $1,195 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 76 | $594 | $6 |
| Ultrasound of heart, follow-up | 13 | $354 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $236 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $65 | $3 |
2019: 22 services
| Long return visit (40+ min) | 203 | $33,598 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $16,263 | $92 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $7,657 | $479 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 101 | $6,823 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,114 | $176 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 79 | $4,979 | $62 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,665 | $212 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 38 | $3,415 | $90 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $2,761 | $162 |
| Hospital discharge day management, 30 minutes or less | 38 | $2,600 | $67 |
| New patient visit (60+ min) | 19 | $2,549 | $134 |
| Return visit (30+ min) | 32 | $2,162 | $55 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,885 | $99 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 201 | $1,559 | $7 |
| New patient visit (45+ min) | 15 | $1,499 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,436 | $65 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 25 | $1,428 | $57 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,171 | $84 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $352 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $234 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $162 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $76 | $3 |
2018: 25 services
| Long return visit (40+ min) | 192 | $35,035 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $17,602 | $93 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $7,985 | $444 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,661 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $6,460 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 89 | $5,753 | $64 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $3,937 | $151 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,705 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $3,687 | $65 |
| New patient visit (60+ min) | 24 | $3,262 | $136 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $2,668 | $89 |
| Return visit (30+ min) | 35 | $2,319 | $55 |
| Hospital discharge day management, 30 minutes or less | 33 | $2,115 | $64 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 26 | $1,611 | $62 |
| New patient visit (45+ min) | 16 | $1,550 | $97 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,467 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 146 | $1,166 | $7 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,073 | $98 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $902 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $358 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $240 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $231 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $160 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $113 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $52 | $3 |
2017: 17 services
| Long return visit (40+ min) | 144 | $24,481 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $12,312 | $93 |
| Return visit (30+ min) | 117 | $9,661 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,246 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,394 | $65 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $4,116 | $242 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $3,590 | $55 |
| New patient visit (60+ min) | 23 | $3,451 | $150 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,629 | $88 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $2,623 | $175 |
| Hospital discharge day management, 30 minutes or less | 38 | $2,579 | $66 |
| New patient visit (45+ min) | 13 | $1,499 | $115 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,461 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 144 | $1,382 | $7 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 20 | $1,036 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $260 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $242 | $13 |
2016: 25 services
| Return visit (30+ min) | 172 | $26,277 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $10,258 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $6,962 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,643 | $92 |
| Return visit (30+ min) | 83 | $6,629 | $69 |
| Long return visit (40+ min) | 35 | $5,131 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,933 | $171 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $3,475 | $267 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,173 | $118 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $2,968 | $56 |
| Long return visit (40+ min) | 29 | $2,953 | $98 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,824 | $217 |
| Short return visit (20+ min) | 40 | $2,586 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 126 | $2,335 | $15 |
| Hospital discharge day management, more than 30 minutes | 21 | $2,049 | $98 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,778 | $89 |
| New patient visit (45+ min) | 12 | $1,625 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 102 | $940 | $7 |
| Hospital discharge day management, 30 minutes or less | 11 | $724 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $432 | $33 |
| External ekg recording for more than 48 hours up to 21 days | 14 | $348 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $321 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $290 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $276 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $46 | $3 |
2015: 33 services
| Return visit (30+ min) | 188 | $34,972 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $16,067 | $518 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $12,369 | $225 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $10,581 | $258 |
| Short return visit (20+ min) | 99 | $9,972 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $8,208 | $65 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 31 | $8,201 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 64 | $7,881 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 116 | $6,634 | $56 |
| Injection, regadenoson, 0.1 mg | 31 | $5,155 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 17 | $4,615 | $271 |
| New patient visit (45+ min) | 26 | $3,805 | $146 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 147 | $3,132 | $16 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,946 | $109 |
| External shock to heart to regulate heart beat | 16 | $2,234 | $112 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,168 | $99 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 32 | $2,111 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 198 | $2,065 | $8 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,926 | $35 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 16 | $1,038 | $65 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $1,009 | $84 |
| Programming of dual lead pacemaker system | 14 | $959 | $50 |
| Hospital discharge day management, 30 minutes or less | 12 | $870 | $67 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $848 | $37 |
| External ekg recording for more than 48 hours up to 21 days | 20 | $581 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 45 | $577 | $13 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 20 | $485 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 18 | $444 | $25 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 12 | $276 | $23 |
| Injection, aminophyllin, up to 250 mg | 20 | $259 | None |
| Ultrasound of heart blood flow, valves and chambers | 23 | $169 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $91 | $3 |
| Infusion, normal saline solution, 250 cc | 31 | $10 | None |
2014: 29 services
| Return visit (30+ min) | 201 | $36,953 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $19,821 | $508 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 50 | $11,895 | $229 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 38 | $10,283 | $132 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $7,011 | $501 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $6,689 | $64 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $6,635 | $276 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,923 | $174 |
| Short return visit (20+ min) | 70 | $5,399 | $60 |
| New patient visit (45+ min) | 35 | $5,133 | $147 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,801 | $192 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 73 | $4,215 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,301 | $122 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 29 | $3,222 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 38 | $2,495 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 138 | $2,478 | $15 |
| Programming of dual lead pacemaker system | 20 | $2,183 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 214 | $2,148 | $8 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,787 | $94 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,651 | $97 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $1,185 | $35 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $967 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 65 | $849 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $617 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $537 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 20 | $456 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $125 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $67 | $3 |
| Infusion, normal saline solution, 250 cc | 38 | $14 | None |
2013: 30 services
| Return visit (30+ min) | 191 | $36,283 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $22,998 | $523 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 44 | $10,527 | $229 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,090 | $174 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $10,057 | $132 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $9,088 | $505 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $8,797 | $183 |
| Injection, regadenoson, 0.1 mg | 44 | $7,383 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $6,751 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,562 | $62 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $5,541 | $222 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 564 | $5,511 | $7 |
| Short return visit (20+ min) | 62 | $4,588 | $61 |
| New patient visit (45+ min) | 31 | $4,482 | $145 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 129 | $3,089 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 45 | $3,028 | $67 |
| External shock to heart to regulate heart beat | 17 | $1,816 | $107 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $1,625 | $34 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,440 | $85 |
| Programming of dual lead pacemaker system | 14 | $1,359 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,347 | $90 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,221 | $64 |
| New patient visit (30+ min) | 12 | $1,206 | $100 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $669 | $56 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 25 | $569 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 36 | $433 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $101 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $52 | $3 |
| Infusion, normal saline solution, 250 cc | 33 | $35 | None |
| Injection, aminophyllin, up to 250 mg | 12 | $8 | None |
Medicaid work
$7,877 in 2024
Medicaid paid $7,877 for 130 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 87 | $6,256 |
| Return visit (30+ min) | 13 | $1,184 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 30 | $438 |
| 2024 | 130 | 3 | 28 | $7,877 |
| 2023 | 198 | 3 | 30 | $10,733 |
| 2022 | 125 | 3 | 17 | $4,677 |
| 2021 | 101 | 2 | 14 | $5,435 |
| 2020 | 70 | 2 | 15 | $4,345 |
| 2019 | 53 | 2 | 15 | $648 |
| 2018 | 75 | 1 | 17 | $0 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 122 | $9,120 |
| Return visit (30+ min) | 14 | $1,024 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 62 | $588 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 53 | $2,886 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 30 | $1,620 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 42 | $171 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 87 | $4,278 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $1,158 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 57 | $4,345 |
| Telehealth originating site facility fee | 13 | $0 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $648 |
| Hospital outpatient clinic visit for assessment and management of a patient | 41 | $0 |
2018
| Hospital outpatient clinic visit for assessment and management of a patient | 75 | $0 |
Drugs they prescribed that Part D paid
$429,541
Pharmacies billed $429,541 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,531) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
1,183 generic and 348 brand-name prescriptions · $429,541 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 120 | $151,703 | $1,264 |
| Xarelto | 69 | $83,205 | $1,206 |
| Entresto | 49 | $56,278 | $1,149 |
| Farxiga | 40 | $40,720 | $1,018 |
| Multaq | 12 | $26,232 | $2,186 |
See all 21 drugs
| Eliquis | 120 | $151,703 | $1,264 |
| Xarelto | 69 | $83,205 | $1,206 |
| Entresto | 49 | $56,278 | $1,149 |
| Farxiga | 40 | $40,720 | $1,018 |
| Multaq | 12 | $26,232 | $2,186 |
| Repatha Sureclick | 20 | $10,729 | $536 |
| Ranolazine Er | 19 | $3,857 | $203 |
| Metoprolol | 118 | $1,772 | $15 |
| Atorvastatin | 133 | $1,577 | $12 |
| Carvedilol | 132 | $1,202 | $9 |
| Rosuvastatin | 84 | $1,199 | $14 |
| Ezetimibe | 52 | $1,023 | $20 |
| Amlodipine Besylate | 146 | $1,000 | $7 |
| Losartan | 91 | $719 | $8 |
| Lisinopril | 48 | $641 | $13 |
| Spironolactone | 59 | $609 | $10 |
| Clopidogrel | 43 | $600 | $14 |
| Amiodarone | 19 | $564 | $30 |
| Isosorbide Mononitrate Er | 22 | $302 | $14 |
| Furosemide | 70 | $260 | $4 |
| Hydrochlorothiazide | 17 | $49 | $3 |
Year by year
| 2024 | 1,531 | 260 | 0% (0) | 23% | $429,541 |
| 2023 | 1,587 | 283 | 0% (0) | 20% | $413,071 |
| 2022 | 1,607 | 295 | 0% (0) | None | $341,033 |
| 2021 | 1,878 | 320 | 0% (0) | None | $358,927 |
| 2020 | 1,893 | 306 | 0% (0) | 21% | $335,057 |
| 2019 | 1,447 | 261 | 0% (0) | 18% | $195,184 |
| 2018 | 1,386 | 242 | 0% (0) | 19% | $181,606 |
| 2017 | 1,893 | 275 | 0% (0) | 26% | $234,666 |
| 2016 | 2,672 | 296 | None | None | $367,051 |
| 2015 | 2,857 | 298 | None | None | $343,936 |
| 2014 | 2,510 | 286 | None | 35% | $267,058 |
| 2013 | 2,231 | 247 | None | 34% | $208,729 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Eliquis | 102 | $134,856 | $1,322 |
| Xarelto | 82 | $100,975 | $1,231 |
| Entresto | 42 | $53,836 | $1,282 |
| Farxiga | 30 | $33,405 | $1,113 |
| Multaq | 14 | $19,564 | $1,397 |
| Ranolazine Er | 25 | $4,899 | $196 |
| Ezetimibe | 45 | $4,331 | $96 |
| Metoprolol | 139 | $3,054 | $22 |
| Atorvastatin | 148 | $2,955 | $20 |
| Carvedilol | 140 | $2,723 | $19 |
| Rosuvastatin | 91 | $2,623 | $29 |
| Amlodipine Besylate | 130 | $2,255 | $17 |
| Amiodarone | 51 | $2,092 | $41 |
| Losartan | 97 | $1,827 | $19 |
| Lisinopril | 58 | $1,285 | $22 |
| Valsartan | 14 | $1,216 | $87 |
| Olmesartan Medoxomil | 15 | $1,147 | $76 |
| Clopidogrel | 48 | $1,015 | $21 |
| Diltiazem 24hr Er (Cd) | 17 | $909 | $53 |
| Isosorbide Mononitrate Er | 25 | $821 | $33 |
| Spironolactone | 44 | $579 | $13 |
| Furosemide | 78 | $569 | $7 |
| Nitroglycerin | 11 | $479 | $44 |
| Pantoprazole | 11 | $175 | $16 |
2022: 26 drugs
| Eliquis | 130 | $156,824 | $1,206 |
| Xarelto | 49 | $54,615 | $1,115 |
| Entresto | 31 | $35,732 | $1,153 |
| Multaq | 11 | $22,908 | $2,083 |
| Farxiga | 12 | $8,207 | $684 |
| Ranolazine Er | 14 | $4,433 | $317 |
| Metoprolol | 163 | $3,250 | $20 |
| Rosuvastatin | 94 | $3,217 | $34 |
| Atorvastatin | 178 | $3,115 | $17 |
| Ezetimibe | 36 | $2,976 | $83 |
| Carvedilol | 134 | $2,562 | $19 |
| Potassium Chloride | 15 | $2,328 | $155 |
| Amlodipine Besylate | 130 | $1,576 | $12 |
| Valsartan | 12 | $1,207 | $101 |
| Lisinopril | 84 | $979 | $12 |
| Losartan | 82 | $945 | $12 |
| Olmesartan Medoxomil | 19 | $897 | $47 |
| Clopidogrel | 33 | $876 | $27 |
| Furosemide | 63 | $874 | $14 |
| Amiodarone | 38 | $859 | $23 |
| Irbesartan | 12 | $794 | $66 |
| Isosorbide Mononitrate Er | 30 | $717 | $24 |
| Pantoprazole | 14 | $354 | $25 |
| Spironolactone | 29 | $214 | $7 |
| Hydrochlorothiazide | 13 | $81 | $6 |
| Metoprolol | 11 | $59 | $5 |
2021: 29 drugs
| Eliquis | 158 | $167,493 | $1,060 |
| Xarelto | 64 | $62,819 | $982 |
| Multaq | 13 | $26,713 | $2,055 |
| Entresto | 25 | $19,703 | $788 |
| Ranolazine Er | 26 | $5,859 | $225 |
| Ezetimibe | 59 | $4,873 | $83 |
| Metoprolol | 145 | $3,767 | $26 |
| Atorvastatin | 211 | $3,659 | $17 |
| Rosuvastatin | 63 | $3,376 | $54 |
| Carvedilol | 163 | $2,687 | $16 |
| Potassium Chloride | 25 | $2,245 | $90 |
| Amlodipine Besylate | 130 | $1,796 | $14 |
| Losartan | 102 | $1,403 | $14 |
| Olmesartan Medoxomil | 22 | $1,206 | $55 |
| Valsartan | 25 | $1,164 | $47 |
| Diltiazem 24hr Er (Cd) | 13 | $1,001 | $77 |
| Isosorbide Mononitrate Er | 44 | $1,000 | $23 |
| Amiodarone | 33 | $928 | $28 |
| Lisinopril | 93 | $916 | $10 |
| Bumetanide | 15 | $907 | $60 |
| Furosemide | 84 | $831 | $10 |
| Irbesartan | 12 | $640 | $53 |
| Clopidogrel | 39 | $575 | $15 |
| Chlorthalidone | 12 | $425 | $35 |
| Megestrol Acetate | 12 | $402 | $33 |
| Pravastatin | 12 | $283 | $24 |
| Pantoprazole | 12 | $228 | $19 |
| Spironolactone | 29 | $207 | $7 |
| Hydrochlorothiazide | 15 | $121 | $8 |
2020: 31 drugs
| Eliquis | 132 | $132,470 | $1,004 |
| Xarelto | 81 | $75,717 | $935 |
| Multaq | 14 | $22,762 | $1,626 |
| Entresto | 24 | $16,837 | $702 |
| Brilinta | 21 | $15,654 | $745 |
| Ranolazine Er | 30 | $6,319 | $211 |
| Metoprolol | 130 | $4,578 | $35 |
| Rosuvastatin | 45 | $3,668 | $82 |
| Atorvastatin | 217 | $3,216 | $15 |
| Ezetimibe | 50 | $3,148 | $63 |
| Amiodarone | 43 | $2,255 | $52 |
| Carvedilol | 175 | $2,217 | $13 |
| Losartan | 107 | $1,237 | $12 |
| Amlodipine Besylate | 131 | $1,015 | $8 |
| Valsartan | 15 | $927 | $62 |
| Furosemide | 103 | $906 | $9 |
| Potassium Chloride | 22 | $833 | $38 |
| Lisinopril | 101 | $789 | $8 |
| Felodipine Er | 11 | $776 | $71 |
| Clopidogrel | 48 | $743 | $15 |
| Irbesartan | 17 | $701 | $41 |
| Chlorthalidone | 14 | $672 | $48 |
| Nitroglycerin | 19 | $656 | $35 |
| Isosorbide Mononitrate Er | 35 | $644 | $18 |
| Olmesartan Medoxomil | 20 | $630 | $32 |
| Pravastatin | 14 | $389 | $28 |
| Metolazone | 13 | $387 | $30 |
| Pantoprazole | 15 | $202 | $13 |
| Spironolactone | 20 | $138 | $7 |
| Hydrochlorothiazide | 25 | $136 | $5 |
| Metoprolol | 11 | $37 | $3 |
2019: 25 drugs
| Xarelto | 69 | $59,247 | $859 |
| Eliquis | 53 | $58,959 | $1,112 |
| Brilinta | 22 | $15,959 | $725 |
| Ranolazine Er | 29 | $8,614 | $297 |
| Metoprolol | 137 | $4,733 | $35 |
| Rosuvastatin | 45 | $3,609 | $80 |
| Ezetimibe | 32 | $3,168 | $99 |
| Atorvastatin | 157 | $2,901 | $18 |
| Carvedilol | 117 | $1,508 | $13 |
| Lisinopril | 95 | $1,127 | $12 |
| Amlodipine Besylate | 127 | $1,088 | $9 |
| Olmesartan Medoxomil | 19 | $988 | $52 |
| Furosemide | 99 | $825 | $8 |
| Losartan | 87 | $773 | $9 |
| Amiodarone | 15 | $718 | $48 |
| Clopidogrel | 43 | $617 | $14 |
| Nitroglycerin | 16 | $392 | $24 |
| Isosorbide Mononitrate Er | 28 | $388 | $14 |
| Potassium Chloride | 13 | $381 | $29 |
| Warfarin | 15 | $252 | $17 |
| Clonidine | 13 | $180 | $14 |
| Benazepril | 11 | $148 | $13 |
| Spironolactone | 13 | $93 | $7 |
| Metoprolol | 14 | $80 | $6 |
| Hydrochlorothiazide | 16 | $50 | $3 |
2018: 26 drugs
| Eliquis | 74 | $63,001 | $851 |
| Xarelto | 54 | $47,053 | $871 |
| Ranexa | 26 | $16,967 | $653 |
| Brilinta | 26 | $14,332 | $551 |
| Spiriva | 12 | $5,067 | $422 |
| Metoprolol | 117 | $4,509 | $39 |
| Ezetimibe | 49 | $4,470 | $91 |
| Atorvastatin | 108 | $2,220 | $21 |
| Rosuvastatin | 32 | $1,506 | $47 |
| Amiodarone | 20 | $1,170 | $58 |
| Carvedilol | 138 | $1,019 | $7 |
| Nitroglycerin | 22 | $739 | $34 |
| Lisinopril | 98 | $634 | $6 |
| Olmesartan Medoxomil | 11 | $584 | $53 |
| Isosorbide Mononitrate Er | 32 | $554 | $17 |
| Amlodipine Besylate | 88 | $544 | $6 |
| Losartan | 47 | $451 | $10 |
| Clopidogrel | 38 | $430 | $11 |
| Warfarin | 21 | $357 | $17 |
| Furosemide | 83 | $310 | $4 |
| Hydralazine | 19 | $291 | $15 |
| Potassium Chloride | 18 | $255 | $14 |
| Spironolactone | 29 | $189 | $7 |
| Benazepril | 16 | $80 | $5 |
| Atenolol | 11 | $75 | $7 |
| Hydrochlorothiazide | 23 | $74 | $3 |
2017: 31 drugs
| Eliquis | 140 | $76,483 | $546 |
| Xarelto | 87 | $39,501 | $454 |
| Ranexa | 71 | $34,146 | $481 |
| Multaq | 24 | $23,950 | $998 |
| Zetia | 12 | $6,141 | $512 |
| Ezetimibe | 29 | $4,888 | $169 |
| Atorvastatin | 193 | $3,935 | $20 |
| Metoprolol | 82 | $3,194 | $39 |
| Amiodarone | 24 | $2,360 | $98 |
| Rosuvastatin | 28 | $1,922 | $69 |
| Edarbi | 11 | $1,912 | $174 |
| Isosorbide Mononitrate Er | 83 | $1,559 | $19 |
| Carvedilol | 218 | $1,396 | $6 |
| Chlorthalidone | 32 | $1,059 | $33 |
| Felodipine Er | 28 | $1,030 | $37 |
| Clopidogrel | 25 | $897 | $36 |
| Lisinopril | 146 | $693 | $5 |
| Furosemide | 139 | $598 | $4 |
| Pravastatin | 17 | $590 | $35 |
| Diltiazem 24hr Er | 15 | $510 | $34 |
| Amlodipine Besylate | 105 | $480 | $5 |
| Losartan | 39 | $401 | $10 |
| Sotalol | 15 | $314 | $21 |
| Warfarin | 19 | $277 | $15 |
| Metoprolol | 33 | $152 | $5 |
| Spironolactone | 20 | $112 | $6 |
| Simvastatin | 14 | $99 | $7 |
| Pantoprazole | 11 | $88 | $8 |
| Hydrochlorothiazide | 18 | $66 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $54 | $5 |
| Lisinopril-Hydrochlorothiazide | 11 | $41 | $4 |
2016: 44 drugs
| Eliquis | 159 | $85,232 | $536 |
| Xarelto | 128 | $68,535 | $535 |
| Ranexa | 95 | $54,524 | $574 |
| Multaq | 37 | $26,815 | $725 |
| Zetia | 55 | $22,749 | $414 |
| Crestor | 29 | $12,036 | $415 |
| Effient | 15 | $7,108 | $474 |
| Benicar | 19 | $6,936 | $365 |
| Amiodarone | 52 | $5,510 | $106 |
| Atorvastatin | 257 | $4,926 | $19 |
| Metoprolol | 101 | $4,404 | $44 |
| Dexilant | 13 | $3,172 | $244 |
| Carvedilol | 276 | $2,238 | $8 |
| Edarbi | 13 | $2,116 | $163 |
| Clopidogrel | 85 | $1,698 | $20 |
| Chlorthalidone | 50 | $1,518 | $30 |
| Rosuvastatin | 14 | $1,429 | $102 |
| Pravastatin | 39 | $1,292 | $33 |
| Flecainide Acetate | 23 | $1,269 | $55 |
| Felodipine Er | 30 | $1,130 | $38 |
| Isosorbide Mononitrate Er | 78 | $1,112 | $14 |
| Warfarin | 51 | $1,088 | $21 |
| Valsartan | 15 | $1,012 | $67 |
| Dilt-Xr | 18 | $885 | $49 |
| Losartan | 73 | $880 | $12 |
| Amlodipine Besylate | 166 | $854 | $5 |
| Diltiazem 24hr Er | 18 | $794 | $44 |
| Telmisartan-Hydrochlorothiazid | 12 | $785 | $65 |
| Furosemide | 141 | $781 | $6 |
| Lisinopril | 121 | $716 | $6 |
| Omeprazole | 25 | $698 | $28 |
| Cilostazol | 31 | $607 | $20 |
| Diltiazem 24hr Cd | 12 | $576 | $48 |
| Fenofibrate | 15 | $497 | $33 |
| Potassium Chloride | 17 | $495 | $29 |
| Sotalol | 17 | $490 | $29 |
| Metoprolol | 66 | $415 | $6 |
| Levothyroxine | 12 | $264 | $22 |
| Spironolactone | 18 | $200 | $11 |
| Simvastatin | 25 | $175 | $7 |
| Benazepril | 23 | $135 | $6 |
| Hydrochlorothiazide | 16 | $129 | $8 |
| Lisinopril-Hydrochlorothiazide | 11 | $104 | $9 |
| Clonidine | 12 | $94 | $8 |
2015: 45 drugs
| Eliquis | 155 | $75,943 | $490 |
| Xarelto | 128 | $59,861 | $468 |
| Ranexa | 89 | $50,528 | $568 |
| Multaq | 35 | $24,300 | $694 |
| Crestor | 58 | $19,438 | $335 |
| Zetia | 53 | $17,915 | $338 |
| Effient | 27 | $8,775 | $325 |
| Metoprolol | 123 | $5,073 | $41 |
| Atorvastatin | 207 | $4,568 | $22 |
| Amiodarone | 57 | $4,138 | $73 |
| Benicar | 17 | $4,014 | $236 |
| Dexilant | 11 | $2,340 | $213 |
| Carvedilol | 279 | $1,973 | $7 |
| Edarbi | 12 | $1,723 | $144 |
| Clopidogrel | 107 | $1,681 | $16 |
| Telmisartan | 19 | $1,535 | $81 |
| Pravastatin | 36 | $1,335 | $37 |
| Clonidine | 12 | $1,319 | $110 |
| Warfarin | 69 | $1,318 | $19 |
| Flecainide Acetate | 32 | $1,120 | $35 |
| Valsartan | 22 | $1,087 | $49 |
| Omeprazole | 38 | $1,058 | $28 |
| Isosorbide Mononitrate Er | 79 | $928 | $12 |
| Losartan | 64 | $910 | $14 |
| Amlodipine Besylate | 174 | $841 | $5 |
| Cilostazol | 44 | $815 | $19 |
| Lisinopril | 121 | $764 | $6 |
| Felodipine Er | 18 | $713 | $40 |
| Fenofibrate | 22 | $708 | $32 |
| Furosemide | 155 | $708 | $5 |
| Metoprolol | 100 | $698 | $7 |
| Sotalol | 29 | $662 | $23 |
| Chlorthalidone | 19 | $599 | $32 |
| Digoxin | 12 | $334 | $28 |
| Potassium Chloride | 11 | $315 | $29 |
| Metformin | 16 | $284 | $18 |
| Levothyroxine | 15 | $260 | $17 |
| Amlodipine Besylate-Benazepril | 11 | $250 | $23 |
| Simvastatin | 45 | $236 | $5 |
| Clonidine | 19 | $157 | $8 |
| Klor-Con 8 | 11 | $147 | $13 |
| Meclizine | 11 | $136 | $12 |
| Metoclopramide | 11 | $131 | $12 |
| Spironolactone | 16 | $93 | $6 |
| Benazepril | 11 | $72 | $7 |
2014: 44 drugs
| Xarelto | 126 | $51,648 | $410 |
| Eliquis | 106 | $34,869 | $329 |
| Ranexa | 69 | $33,276 | $482 |
| Crestor | 111 | $27,039 | $244 |
| Multaq | 20 | $11,212 | $561 |
| Zetia | 44 | $9,830 | $223 |
| Pradaxa | 19 | $8,939 | $470 |
| Diovan | 19 | $6,476 | $341 |
| Atorvastatin | 224 | $4,723 | $21 |
| Effient | 15 | $4,323 | $288 |
| Benicar | 14 | $3,202 | $229 |
| Carvedilol | 239 | $2,962 | $12 |
| Metoprolol | 64 | $2,893 | $45 |
| Bystolic | 17 | $2,700 | $159 |
| Clopidogrel | 107 | $2,529 | $24 |
| Amiodarone | 61 | $2,291 | $38 |
| Telmisartan | 21 | $2,076 | $99 |
| Cilostazol | 50 | $2,015 | $40 |
| Propafenone | 25 | $1,367 | $55 |
| Edarbi | 11 | $1,255 | $114 |
| Losartan | 55 | $999 | $18 |
| Lisinopril | 110 | $910 | $8 |
| Warfarin | 67 | $898 | $13 |
| Amlodipine Besylate | 152 | $872 | $6 |
| Diltiazem Er | 13 | $631 | $49 |
| Verapamil Er | 14 | $620 | $44 |
| Metoprolol | 90 | $581 | $6 |
| Fenofibrate | 14 | $578 | $41 |
| Potassium Chloride | 15 | $561 | $37 |
| Furosemide | 118 | $529 | $4 |
| Pravastatin | 21 | $518 | $25 |
| Amlodipine Besylate-Benazepril | 12 | $501 | $42 |
| Isosorbide Mononitrate Er | 44 | $435 | $10 |
| Nitrostat | 16 | $402 | $25 |
| Digoxin | 12 | $358 | $30 |
| Simvastatin | 47 | $345 | $7 |
| Omeprazole | 15 | $318 | $21 |
| Sotalol | 16 | $297 | $19 |
| Levothyroxine | 11 | $221 | $20 |
| Lisinopril-Hydrochlorothiazide | 20 | $182 | $9 |
| Klor-Con 8 | 12 | $160 | $13 |
| Atenolol | 20 | $94 | $5 |
| Spironolactone | 16 | $89 | $6 |
| Hydrochlorothiazide | 18 | $82 | $5 |
2013: 38 drugs
| Xarelto | 114 | $38,207 | $335 |
| Ranexa | 67 | $28,903 | $431 |
| Crestor | 115 | $24,605 | $214 |
| Pradaxa | 39 | $13,095 | $336 |
| Multaq | 21 | $9,187 | $437 |
| Zetia | 43 | $8,600 | $200 |
| Diovan | 31 | $7,996 | $258 |
| Propafenone | 33 | $5,518 | $167 |
| Atorvastatin | 159 | $5,455 | $34 |
| Clopidogrel | 89 | $4,772 | $54 |
| Eliquis | 14 | $4,688 | $335 |
| Benicar | 26 | $4,526 | $174 |
| Metoprolol | 83 | $3,417 | $41 |
| Carvedilol | 193 | $2,668 | $14 |
| Cilostazol | 59 | $2,651 | $45 |
| Amlodipine Besylate | 124 | $1,437 | $12 |
| Clonidine | 12 | $1,338 | $112 |
| Losartan | 43 | $1,058 | $25 |
| Lisinopril | 87 | $953 | $11 |
| Amiodarone | 53 | $928 | $18 |
| Warfarin | 76 | $904 | $12 |
| Fenofibrate | 14 | $822 | $59 |
| Diltiazem Er | 15 | $793 | $53 |
| Simvastatin | 74 | $717 | $10 |
| Isosorbide Mononitrate Er | 54 | $707 | $13 |
| Amlodipine Besylate-Benazepril | 13 | $686 | $53 |
| Metoprolol | 75 | $661 | $9 |
| Sotalol | 24 | $638 | $27 |
| Potassium Chloride | 12 | $468 | $39 |
| Furosemide | 92 | $426 | $5 |
| Pravastatin | 13 | $378 | $29 |
| Omeprazole | 13 | $374 | $29 |
| Nitrostat | 22 | $333 | $15 |
| Lisinopril-Hydrochlorothiazide | 20 | $320 | $16 |
| Digox | 22 | $263 | $12 |
| Spironolactone | 22 | $242 | $11 |
| Atenolol | 22 | $159 | $7 |
| Hydrochlorothiazide | 18 | $55 | $3 |
Money from drug and device companies
$301 in 2025
| 2025 | 3 | 3 | None | $301 |
| 2024 | 2 | 2 | None | $201 |
| 2022 | 2 | 3 | None | $147 |
| 2021 | 2 | 3 | None | $64 |
| 2020 | 6 | 16 | None | $503 |
| 2019 | 19 | 65 | None | $1,671 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $168 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $108 | 1 payment
|
| Abbott Laboratories | Portico | $25 | 1 payment
|
See all 3 published payments
| Abbott Laboratories | Meals · 2025-11-26 | Portico | $25 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-12 | Lifevest | $108 |
| Heartflow | Meals · 2025-10-28 | Ffrct | $168 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $201
| Edwards Lifesciences | None | $102 | 1 payment
|
| Terumo Medical | Glidesheath Slender | $99 | 1 payment
|
2022: $147
| Abiomed | Impella | $128 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $20 | 1 payment
|
2021: $64
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $39 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $25 | 1 payment
|
2020: $503
| Janssen Pharmaceuticals | Xarelto | $161 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $159 | 5 payments
|
| CathWorks | Ffrangio System | $74 | 3 payments
|
| Astellas Pharma US | Lexiscan | $61 | 3 payments
|
| Amgen | Repatha | $32 | 1 payment
|
| iRhythm Technologies | Zio Patch | $16 | 1 payment
|
2019: $1,671
| Amgen | Repatha | $247 | 9 payments
|
| Janssen Pharmaceuticals | Xarelto | $207 | 9 payments
|
| Medtronic Vascular | Corevalve Evolut | $198 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $182 | 10 payments
|
| Actelion Pharmaceuticals US | Opsumit | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $121 | 6 payments
|
| Abiomed | Impella | $95 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $84 | 3 payments
|
| Boston Scientific | Watchman | $75 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $73 | 4 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $49 | 2 payments
|
| Astellas Pharma US | Lexiscan | $46 | 2 payments
|
| Sanofi-Aventis U.S. | Praluent | $43 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $34 | 2 payments
|
| HeartFlow | None | $24 | 2 payments
|
| CathWorks | Ffrangio System | $21 | 1 payment
|
| Chiesi USA | Kengreal | $17 | 1 payment
|
| iRhythm Technologies | Zio Patch | $15 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1013917046
- Licence
- CA A88258California A88258: Current · expires 2027-11-30
- Trained
- University of Virginia School of Medicine, 1996 · 30 years ago
- Group
- University of California San Francisco · Regents of the University of California
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 3196127
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 1 Daniel Burnham Ct Ste 260c, San Francisco, CA, 94109
- NPI first listed
- 2005-08-01
- NPI last updated
- 2025-12-15
- NPI record certified
- 2025-12-15
This is when the NPI record was last certified, not a medical board exam.